myDNA Pharmacogenomic Test
Fast-track healthcare goals and enable personalization for every patient with pharmacogenomic-guided prescribing.
Clinic Sign-in
Fast-track healthcare goals and enable personalization for every patient with pharmacogenomic-guided prescribing.
Clinic Sign-inWhat is a
Pharmacogenomic Test?
Pharmacogenomics (PGx) is the study of how genetic variations influence the way an individual responds to medications.
PGx is now enabling doctors to test for specific genetic changes to predict whether a patient may have a normal response, a poor response, or a higher risk of side effects before prescribing a specific medication.
Tests We Offer
We offer two PGX Tests:
PGX Testing Benefits
May help reduce the risk of experiencing medication side effects.
By testing certain genetic markers, the risk of possible side effects may be predicted even prior to starting the medication. This can help personalize dosage and choice of medication.
May reduce some of the guesswork around medication selection.
PGx testing may help to reduce some of the "trial and error" that can be involved in prescribing medications. The myDNA test provides you with information that can further assist in prescribing an effective medication sooner, potentially saving you and your patient time and money.
Results last a lifetime.
The test results presented in the report will assist you and your patient, now and in the future, to decide if one of the covered medications is right for your patient.
myDNA Psychotropic PGX Test
The myDNA Psychotropic Test is a PGx test that analyzes how certain genetic variations my affect the response to a range of psychotropic medications used in the treatment of depression, anxiety, ADHD, and other mental health conditions.
Our PGx reports are simple and easy for you to follow and share with your patient. All PGx reports include detailed interpretations and recommendations with references to international PGx guidelines for each gene-drug pair, including suggestions of how to adjust dosages, and where appropriate, to select an alternative medication.
Request Sample ReportMedications Covered
The myDNA Psychotropic test covers 41 commonly psychotropic medications.
Genes Covered
The myDNA Psychotropic test covers a broad range of genes which covers up to 14 genes relevant for psychotropic medications.
How to Order
01
Register with Gene by Gene by filling out this form. Once registered, place your order on client.genebygene.com.
02
Swab your patient using the myDNA test collection kit, OR your patient can collect the sample at home using our at-home patient collection kit called myDNA Direct.
03
The sample is sent to the Gene by Gene lab for analysis. You will be notified via email once the results are ready. Results will be delivered approximately 5 days from the time the sample arrives at the lab.
04
Sign in to the client.genebygene.com portal to access the report, and consult with your patient to adjust medications as required.
If you have any questions or require further information, please contact our customer service center via email or call Gene by Gene at 713-474-2401.
Cost & Pricing
The cost of the Psychotropic Medications test is $330.
The Psychotropic Medications test is covered by insurance, meaning the out-of-pocket cost to the consumer can vary based on payment options.
Payment Options
Gene by Gene believes everyone should have access to quality genetic testing services that are affordable. Therefore, we offer many options for payment.
Billing Process Breakdown
Sample Processing
Once the sample arrives at Gene by Gene, we will confirm the cost. If the cost of the test is more than $330, Gene by Gene will call prior to processing the sample.
Billing Insurance
Once the sample is processed, Gene by Gene will submit the claim to the nominated insurance company.
Receive EOB
After processing the claim, the nominated health insurance provider will send an Explanation of Benefits (EOB), typically within 50 days. Please note, the EOB is not a bill but details the amount the insurance has covered for the test.
Please note: A bill from the insurance provider may be received for the coinsurance or deductible based on the insurance policy.
The Bill
Once the claim is complete, we will send a statement that includes the balance, which can be paid online via PayPal, by phone, or via mail. Insurance processing takes time, and it may be several months before receiving this bill from us.
myDNA Multiple Category Test
The myDNA Multiple Category Test is a PGx test that analyzes how certain genetic variations my affect the response to a range of medications used in various medical specialities such as psychiatry, cardiology, gastroenterology, and pain medicine.
Our PGx reports are simple and easy for you to follow and share with your patient. All PGx reports include detailed interpretations and recommendations with references to international PGx guidelines for each gene-drug pair, including suggestions of how to adjust dosages, and where appropriate, to select an alternative medication.
Request Sample ReportMedication Categories
The main medical categories that are covered are highlighted below; however, insights into other medications are also included with the Multiple Category test.
Medications Covered
The myDNA Multiple Category test covers over 160 medications.
How to Order
01
Register with Gene by Gene by filling out this form. Once registered, place your order on client.genebygene.com.
02
Swab your patient using the myDNA test collection kit, OR your patient can collect the sample at home using our at-home patient collection kit called myDNA Direct.
03
The sample is sent to the Gene by Gene lab for analysis. You will be notified via email once the results are ready. Results will be delivered approximately 5 days from the time the sample arrives at the lab.
04
Sign in to the client.genebygene.com portal to access the report, and consult with your patient to adjust medications as required.
If you have any questions or require further information, please contact our customer service center via email or call Gene by Gene at 713-474-2401.
Cost & Pricing
The Multiple Medications test is not covered by insurance.
The Out-of-pocket cost is $399.
Interest-free Payment Plans: Interest-free payment plans are available if the out-of-pocket cost for the test exceeds $100.
To set up a payment plan, please contact our client services team at 1-346-510-4003.
Pharmacogenomic Testing Resources
The Latest Research
A landmark study has been published in The Lancet which shows that adverse drug reactions (ADRs) were reduced by 30% in individuals who had their drug treatment guided by pharmacogenomics.
Guidelines & More
myDNA ensures the clinical reporting of pharmacogenomic results is based, where possible, on the most published PGx guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG). These guidelines are routinely updated, peer-reviewed, and published in relevant journals and can be accessed here.
The US Food and Drug Administration (FDA) has also recently published a list of medications with pharmacogenomic associations and recommendations, which are referenced, where relevant, in the myDNA PGx report: https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations
Downloadable Resources
PGX FedEx Shipping Instructions
Inquire about Pharmacogenomic Services Online
Are you interested providing the myDNA Psychotropic PGx test to your patients? Submit your information below and we will contact you to help you get started.
Please note: the myDNA PGx test must be ordered by a registered clinician. If you are a patient/caregiver interested in testing, please contact your clinician. Our clinician registration process is simple, quick, and easy.
Our Expertise
Our clinical team includes clinical pharmacologists, clinical pharmacists, clinical geneticists, and genetic counselors.
Our reports are based on PGx guidelines and primary literature.
Less than 50% of patients are likely to have an adequate response to their first-line antidepressant.(1)
A recent meta-analysis has shown that patients who received pharmacogenomic-guided antidepressant treatment were more likely to achieve symptom remission compared to patients without pharmacogenomic-guided treatment.(2)
Peer-reviewed pharmacogenomic guidelines by international experts offer clinically actionable recommendations on specific gene-drug interactions covering many commonly prescribed psychotropic medications.(3-5)